To overcome the challenge of anti-CAR immune responses and to improve the anti-tumor activity of CD19-specific CAR T cells, we created a new anti-CD19 CAR T cells containing fully human scFv isolated from a phage display library. This evidence concerns the gene CD19 and neoplasm.